Cereno Scientific presents an updated agenda for the Capital Markets Day October 17th, 2024
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for diseases with high unmet medical needs, today announced an updated agenda for the Capital Markets Day on Thursday October 17, 2024.The Capital Markets Day will provide an opportunity for investors, analysts, and media to get insights into Cereno’s clinical and preclinical development portfolio and operations as well as its future growth strategy. The program includes presentations by the Cereno Executive Management Team as well as external speakers The interest for the Capital